Polianta Ltd’s Nu Skin NUS Stock Holding History

Polianta Ltd’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-21,100	Closed	-$1.17M	–	91
2017 Q1	$1.17M	Sell	21,100 -400	-2%	-$20.6K	0.7%	28
2016 Q4	$1.03M	Buy	+21,500	New	+$1.2M	0.56%	58

Other funds holding NUS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

PGP

Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return

Polianta Ltd's NUS Position: Q2 2017 in Review

Polianta Ltd sold out of Nu Skin (NUS) in Q2 2017, closing a stake of 21,100 shares — an estimated $1.17M sold.

Polianta Ltd first reported a position in NUS in Q4 2016 and held it in 2 quarters. The position peaked at $1.17M in Q1 2017. 266 funds tracked by Wall St. Rank hold NUS as of Q2 2017.

Polianta Ltd reported no remaining Nu Skin position as of Q2 2017 after selling out during the quarter.
Polianta Ltd sold 21,100 Nu Skin shares in Q2 2017, an estimated $1.17M.
Polianta Ltd first reported a position in Nu Skin in Q4 2016 and held it in 2 quarters.
Polianta Ltd's Nu Skin position peaked at $1.17M in Q1 2017.
266 funds tracked by Wall St. Rank held Nu Skin as of Q2 2017.

Based on Polianta Ltd's 13F filing for Q2 2017, filed 5 Jul 2017.